PROTAC Degrader

29 Item(s)

per page

Set Descending Direction
    • New


    Catalog No. A17014
    Quick View
    BRD4 protein degrader
    MZ1 is a potent inducer of reversible, long-lasting and selective removal of BRD4 over BRD2 and BRD3. Learn More
  1. PROTAC BET degrader-2

    Catalog No. A18785
    Quick View
    PROTAC BET degrader
    PROTAC BET degrader-2 is a highly potent degrader of Bromodomain and Extra-Terminal (BET) proteins with an IC50 value of 9.6 nM in cell growth inhibition in the RS4;11 cells and capable of achieving tumor regression. Learn More
  2. dBET57

    Catalog No. A19133
    Quick View
    dBET57 is a potent and selective degrader of BRD4BD1 based on the PROTAC technology. Learn More
  3. MZP-55

    Catalog No. A19415
    Quick View
    BRD3/4 degrader
    MZP-55 is a selective degrader of BRD3/4 based on PROTAC technology, with a Kd of 8 nM for Brd4BD2. Learn More
  4. MZP-54

    Catalog No. A19426
    Quick View
    BRD3/4 degrader
    MZP-54 is a selective degrader of BRD3/4 based on PROTAC technology, with a Kd of 4 nM for Brd4BD2. Learn More
  5. dBET1

    Catalog No. A16858
    Quick View
    BRD4 protein degrader
    dBET1 is a potent BRD4 protein degrader based on PROTAC technology with an EC50 of 430 nM. Learn More
  6. THAL-SNS-032

    Catalog No. A19088
    Quick View
    CDK9 degrader PROTAC
    THAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN). Learn More
  7. PROTAC Sirt2 Degrader-1

    Catalog No. A20005
    Quick View
    Sirt2 degrader
    PROTAC Sirt2 Degrader-1 is a SirReal-based PROTAC, acts as a Sirt2 degrader, composed of a highly potent and isotype-selective Sirt2 inhibitor, a linker, and a bona fide cereblon ligand for E3 ubiquitin ligase. Learn More
  8. BETd-260

    Catalog No. A12563
    Quick View
    BET degrader
    BETd-260 is a potent BET degrader based on PROTAC technology, with as low as 30 pM against BRD4 protein in RS4;11 leukemia cell line. Learn More
  9. ARV-771

    Catalog No. A13255
    Quick View
    BET degrader
    ARV-771 is a potent BET degrader based on PROTAC technology with Kds of 34, 4.7, 8.3, 7.6, 9.6, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and BRD4(2), respectively. Learn More
  10. PROTAC ER Degrader-3

    Catalog No. A18519
    Quick View
    PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). Learn More
  11. PROTAC FLT-3 degrader 1

    Catalog No. A18682
    Quick View
    FLT-3 ITD degrader
    PROTAC FLT-3 degrader 1 is an FLT-3 internal tandem duplication (ITD) degrader with an IC50 0.6 nM. Anti-proliferative activity; apoptosis induction. Learn More
  12. PROTAC CRBN Degrader-1

    Catalog No. A18863
    Quick View
    CRBN degrader
    PROTAC CRBN Degrader-1 comprises a cereblon (CRBN) ligand binding group, a linker and an von Hippel-Landau (VHL) binding group. PROTAC CRBN Degrader-1 is an cereblon (CRBN) degrader. Learn More
  13. PROTAC ERRα Degrader-2

    Catalog No. A18904
    Quick View
    ERRa degrader
    PROTAC ERRalpha Degrader-2 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRalpha Degrader-2 is an estrogen-related receptor alpha (ERRa) degrader. Learn More
  14. PROTAC ERRα Degrader-1

    Catalog No. A18910
    Quick View
    ERRα Degrader
    PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an estrogen-related receptor alpha (ERRa) degrader. Learn More
  15. PROTAC ERRα ligand 2

    Catalog No. A18939
    Quick View
    ERRα inverse agonist
    PROTAC ERRα ligand 2 is an estrogen-related receptor α (ERRα) inverse agonist with an IC50 of 5.67 nM. PROTAC ERRα ligand 2 (IC50=5.67 nM) displays a ~11-fold improved potency than XCT790 (IC50=61.3 nM). Learn More
  16. FKBP12 PROTAC dTAG-7

    Catalog No. A19081
    Quick View
    heterobifunctional degrader
    FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional degrader. Learn More
  17. A1874

    Catalog No. A18735
    Quick View
    BRD4-degrading PROTAC
    A1874 is a nutlin-based and BRD4-degrading PROTAC with a DC50 of 32 nM (induce BRD4 degradation in cells). Effective in inhibiting many cancer cell lines proliferation. Learn More
  18. Gefitinib-based PROTAC 3

    Catalog No. A19093
    Quick View
    Gefitinib-based PROTAC 3, conjugating an EGFR binding element to a VHL ligand via a linker, induces EGFR degradation with DC50s of 11.7 nM and 22.3 nM in HCC827(exon 19 del) and H3255 (L858R mutantion) cells, respectively. Learn More
  19. dMCL1-2

    Catalog No. A18378
    Quick View
    MCL-1/PROTAC degrader
    dMCL1-2 is a potent and selective degrader of myeloid cell leukemia 1 (MCL1) based on PROTAC, which binds to MCL1 with a KD of 30 nM. dMCL1-2 activats the cellular apoptosis machinery by degradation of MCL1. Learn More
  20. PROTAC Mcl1 degrader-1

    Catalog No. A18373
    Quick View
    Mcl-1 inhibitor
    PROTAC Mcl1 degrader-1 (compound C3), a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM. Learn More
  21. PROTAC Bcl2 degrader-1

    Catalog No. A18355
    Quick View
    PROTAC Bcl2 degrader-1 (Compound C5) is a PROTAC, which potently and selectively induces the degradation of Bcl-2 (IC50, 4.94 μM; DC50, 3.0 μM) and Mcl-1 (IC50, 11.81 μM) by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1/Bcl-2 dual inhibitor Nap-1. Learn More
  22. ZXH-3-26

    Catalog No. A18399
    Quick View
    PROTAC BRD4 degrader
    ZXH-3-26 is a selective PROTAC BRD4 degrader with a DC50/5h (DC50/5h referring to half-maximal degradation after 5 hours of treatment) of ~ 5 nM. Learn More
  23. ERD-308

    Catalog No. A18446
    Quick View
    ER PROTAC degrader
    ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment. Learn More
  24. MT-802

    Catalog No. A18589
    Quick View
    BTK degrader
    MT-802 is a potent BTK degrader based on PROTAC technology, with a DC50 of 1 nM. MT-802 has potential to treat C481S mutant chronic lymphocytic leukemia (CLL). Learn More
  25. SJFδ

    Catalog No. A18599
    Quick View
    10-atom linker PROTAC
    SJFδ is a 10-atom linker PROTAC. SJFδ degrades p38δ with a DC50 of 46.17?nM, but does not degrade p38α, p38β, or p38γ. Learn More
  26. SJFα

    Catalog No. A18602
    Quick View
    13-atom linker PROTAC
    SJFα is a 13-atom linker PROTAC. SJFα degrades p38α with a DC50 of 7.16??nM, but is far less effective at degrading p38δ (DC50=299?nM) and does not degrade the other p38 isoforms (β and γ) at concentrations up to 2.5??M. Learn More
  27. VZ185

    Catalog No. A18685
    Quick View
    dual BRD7/9 PROTAC degrader
    VZ185 is a potent, fast, and selective dual BRD7/9 PROTAC degrader with DC50s of 4.5 and 1.8 nM, respectively. Learn More
    • New


    Catalog No. A18712
    Quick View
    MDM2 degrader
    MD-224 is a first-in-class and highly potent small-molecule human murine double minute 2 (MDM2) degrader based on the proteolysistargeting chimera (PROTAC) concept. MD-224 has the potential to be a new class of anticancer agent. Learn More

29 Item(s)

per page

Set Descending Direction